VYOME HOLDINGS, INC. Gain (Loss) on Extinguishment of Debt
VYOME HOLDINGS, INC. (HIND) reported Gain (Loss) on Extinguishment of Debt of $24.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2025-08-14
- VYOME HOLDINGS, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-03-31 was $24.00K.
- VYOME HOLDINGS, INC. gain (loss) on extinguishment of debt for the quarter ending 2024-12-31 was $0.00.
- VYOME HOLDINGS, INC. gain (loss) on extinguishment of debt for the quarter ending 2024-09-30 was $0.00.
- VYOME HOLDINGS, INC. gain (loss) on extinguishment of debt for fiscal 2024 was $429.00K.
- VYOME HOLDINGS, INC. gain (loss) on extinguishment of debt for fiscal 2021 was -$2.06M.
- VYOME HOLDINGS, INC. gain (loss) on extinguishment of debt for fiscal 2020 was -$7.71M.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $24.00K 10-Q · filed 2025-08-14 | $24.00K derived: sum of 3 quarters · filed 2025-08-14 | $24.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | $24.00K 10-Q · filed 2025-05-20 | $24.00K derived: sum of 2 quarters · filed 2025-05-20 | $24.00K derived: sum of 3 quarters · filed 2025-05-20 | $453.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $0.00 derived: sum of 2 quarters · filed 2025-04-04 | $429.00K derived: sum of 3 quarters · filed 2025-08-14 | $429.00K 10-K · filed 2025-04-04 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $429.00K derived: sum of 2 quarters · filed 2025-08-14 | $429.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $429.00K 10-Q · filed 2025-08-14 | $429.00K 10-Q · filed 2025-08-14 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $0.00 derived: sum of 2 quarters · filed 2023-04-17 | -$101.00K derived: sum of 3 quarters · filed 2023-04-17 | -$2.06M 10-K · filed 2023-04-17 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$101.00K derived: sum of 2 quarters · filed 2022-11-14 | -$2.06M 10-Q · filed 2022-11-14 | -$7.34M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$101.00K 10-Q · filed 2022-08-19 | -$2.06M 10-Q · filed 2022-08-19 | -$7.34M derived: sum of 3 quarters · filed 2022-08-19 | -$9.78M derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-03-31 | -$1.96M 10-Q · filed 2022-05-23 | -$7.24M derived: sum of 2 quarters · filed 2022-05-23 | -$9.68M derived: sum of 3 quarters · filed 2022-05-23 | |
| 2020-12-31 | -$5.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | -$7.71M derived: sum of 2 quarters · filed 2022-04-08 | -$7.71M 10-K · filed 2022-04-08 | |
| 2020-09-30 | -$2.44M 10-Q · filed 2021-11-12 | -$2.44M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |